Sight-threatening Keratopathy Complicating Anti-TNF Therapy in Crohnʼs Disease
Authors:
- Alexandra ThompsonATAlexandra Thompson
- Stephen MadillSMStephen Madill
- Peter KoayPKPeter Koay
- David MansfieldDMDavid Mansfield
- Jack SatsangiJSJack Satsangi
- 1 January 2014
- journal article
- case report
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 20 (1) , E2-E3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Paradoxical inflammation induced by anti-TNF agents in patients with IBDNature Reviews Gastroenterology & Hepatology, 2012
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics RegisterAnnals of the Rheumatic Diseases, 2009
- Severe Rosacea in a Patient on Infliximab for Ulcerative Colitis: Pathophysiological ConsiderationsActa Dermato-Venereologica, 2009
- Granulomatous rosacea and Crohn’s disease in a patient homozygous for the Crohn‐associated NOD2/CARD15 polymorphism R702WExperimental Dermatology, 2008
- Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody TherapyDermatology, 2007
- Rosacea: I. Etiology, pathogenesis, and subtype classificationJournal of the American Academy of Dermatology, 2004
- Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort studyGastroenterology, 2003
- Rosacea and Ulcerative ColitisJournal of Clinical Gastroenterology, 1990